Gene · 84148
Papers2,655
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,655
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enhanced Co-Adsorption of Alcohols and Amines for Visible Light Driven Oxidative Condensation Using Iron-Based MOF. | Chemistry | 2024 | 38805347 | PubTator, text mining | PubMed |
| KAT8 beyond Acetylation: A Survey of Its Epigenetic Regulation, Genetic Variability, and Implications for Human Health. | Genes (Basel) | 2024 | 38790268 | PubTator, text mining | PubMed |
| KAT8 compound inhibition inhibits the initial steps of PINK1-dependant mitophagy. | Sci Rep | 2024 | 38777823 | PubTator, text mining | PubMed |
| KAT8 enhances the resistance of lung cancer cells to cisplatin by acetylation of PKM2. | Anticancer Drugs | 2024 | 38771737 | PubTator, text mining | PubMed |
| KAT6A deficiency impairs cognitive functions through suppressing RSPO2/Wnt signaling in hippocampal CA3. | Sci Adv | 2024 | 38758792 | PubTator, text mining | PubMed |
| An integrative framework to prioritize genes in more than 500 loci associated with body mass index. | Am J Hum Genet | 2024 | 38754426 | PubTator, text mining | PubMed |
| Machine learning insights into predicting biogas separation in metal-organic frameworks. | Commun Chem | 2024 | 38720065 | PubTator, text mining | PubMed |
| A dual-mode label-free electrochemical immunosensor for ultrasensitive detection of procalcitonin by on-site vulcanization of dual-MOF heterostructure. | Talanta | 2024 | 38703482 | PubTator, text mining | PubMed |
| Mild-Temperature Supercritical Water Confined in Hydrophobic Metal-Organic Frameworks. | J Am Chem Soc | 2024 | 38701635 | PubTator, text mining | PubMed |
| Self-condensation-assisted chemical vapour deposition growth of atomically two-dimensional MOF single-crystals. | Nat Commun | 2024 | 38684675 | PubTator, text mining | PubMed |
| Self-Reinforced MOF-Based Nanogel Alleviates Osteoarthritis by Long-Acting Drug Release. | Adv Mater | 2024 | 38684182 | PubTator, text mining | PubMed |
| Bimetallic Copper-Cerium-Based Metal-Organic Frameworks for Selective Carbon Dioxide Capture. | Langmuir | 2024 | 38668749 | PubTator, text mining | PubMed |
| Enzyme_Metal-Organic Framework Composites as Novel Approach for Microplastic Degradation. | ChemSusChem | 2024 | 38661054 | PubTator, text mining | PubMed |
| Interface Defects and Carrier Regulation in MOF-Derived Co3O4/In2O3 Composite Materials for Enhanced Selective Detection of HCHO. | ACS Appl Mater Interfaces | 2024 | 38659088 | PubTator, text mining | PubMed |
| Robust Activity and Stability of P-Doped Fe-Carbon Composites Derived from MOF for Bromate Reduction. | ACS Appl Mater Interfaces | 2024 | 38634144 | PubTator, text mining | PubMed |
| Recent Progress on Conversion of Lignocellulosic Biomass by MOF-Immobilized Enzyme. | Polymers (Basel) | 2024 | 38611268 | PubTator, text mining | PubMed |
| MOF-Mediated Construction of NiCoMn-LDH Nanoflakes Assembled Co(OH)F Nanorods for Improved Supercapacitive Performance. | Nanomaterials (Basel) | 2024 | 38607108 | PubTator, text mining | PubMed |
| Cellular Trojan Horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies. | Sci Adv | 2024 | 38598629 | PubTator, text mining | PubMed |
| Protein crotonylation: Basic research and clinical diseases. | Biochem Biophys Rep | 2024 | 38586826 | PubTator, text mining | PubMed |
| Building synergistic multiple active sites in branch-leaf nanostructured carbon nanofiber derived from MOF/COF hybrid for flexible wearable Zn-air battery. | J Colloid Interface Sci | 2024 | 38583208 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84148/papers?page=18